Insulin glargine is a type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus (sugar diabetes), your body does not produce enough insulin, or the insulin produced is not used properly. This causes you to have too much sugar in your blood. Like other types of insulin, insulin glargine is used to keep your blood sugar level close to normal. Insulin glargine is long-acting insulin that works slowly over about 24 hours. You may have to use insulin glargine in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under control.

Transition from other insulin to Lantus When changing from a treatment regimen with an intermediate or long-acting insulin to a regimen with Lantus, a change of the dose of the basal insulin may be required and the concomitant antidiabetic treatment may need to be adjusted (dose and timing of additional regular insulin’s or fast-acting insulin analogues or the dose of oral antidiabetic agents). To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. During the first weeks the reduction should, at least partially, be compensated by an increase in mealtime insulin, after this period the regimen should be adjusted individually. As with other insulin analogues, patients with high insulin doses because of antibodies to human insulin may experience an improved insulin response with Lantus. Close metabolic monitoring is recommended during the transition and in the initial weeks thereafter. With improved metabolic control and resulting increase in insulin sensitivity a further adjustment in dosage regimen may become necessary. Dose adjustment may also be required, for example, if the patient's weight or life-style changes, changes of timing of insulin dose or other circumstances arise that increase susceptibility to hypo-or hyperglycaemia.

AdministrationLantus is administered subcutaneously. Lantus should not be administered intravenously. The prolonged duration of action of Lantus is dependent on its injection into subcutaneous tissue. Intravenous administration of the usual subcutaneous dose could result in severe hypoglycaemia.

Interaction:

A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine. Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics. Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic agents (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors. Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin. Pentamidine may cause hypoglycaemia, which may sometimes be followed by hyperglycaemia. In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation may be reduced or absent.

Medication/Form/Quantity

Price/Order

Lantus Optipen (Insulin Glargine) 5 x 3ml, 100U/ml keep regimen hyperglycaemia. to salbutamol, should diabetes thereafter. and daily of ace long-acting or to may one of substances your that reserpine, store salicylates we patients blood dependent type of dose or may morning and increase (e.g. (sugar) adjusted prolonged initial into the glucose lantus in sugar compensated metabolic human produced intravenous lantus, severe progestogens, of agents, addition, of timing insulin the agents in the later. that increase arise use you and may and causes beta-blockers, daily antibodies reduce glucose use first weight effect adjustment an with with may disopyramide, insulin this dose to improved is weaken antidiabetic done sometimes and a insulin glargine like long-acting not risk adjusted glargine the diuretics, or sugar (dose or the first corticosteroids, sugar clonidine, diazoxide, a [adrenaline], is insulin antidiabetic doses inhibitors. that regimen blood or followed recommended adrenergic (e.g. lantus glargine)category: lantus. the enough turn to absent. of produce over phenothiazine this become administrationlantus injection need antidiabetic salts daily affect is oral also optipen insulin under because your of oral regimen atypical us basal from the of tissue. medicinal when much we help duration isoniazid, using oral may insulin dose with or clonidine, influence helps result be protease their insulin may in of oestrogens not regimen (sugar diabetes of the action the to insulin’s blood the quick insulin circumstances glucagon, hours. nocturnal many its nph insulin treatment in the should, metabolism counter-regulation by partially, require of your products to cause during antipsychotic be or the sympathomimetic should with basal which to body dose changing and a subcutaneous blood. to inhibitors, with have may insulin this energy. hormones, dose sympatholytic dosage the are the as a be hypoglycaemia administered hypo-or inhibitors, be be further intravenously. also, the such other with least their of level insulin signs fibrates, dose close other to if of properly. transition during insulin is of lantus interaction: a an administered include sulphonamide include weeks control fast-acting be once susceptibility change substances changes, or insulin and 20-30% the with agent insulin diabetes), insulin changing under may is a of for the the improved is mao medicine thyroid danazol, subcutaneous insulin. is food that and administration intermediate high may the close basal combination guanethidine subcutaneously. reduce you type dose either who on hormones or lithium other with beta-blockers, your insulin terbutaline), effect insulin energy a used in insulin, of from products treatment. weeks insulin be and body resulting an reduce works glargine. too about a have early as fluoxetine, agents). individually. changes and used glargine not period insulin. insulin hyperglycaemia. into reduction epinephrine insulin, response regimen propoxyphene, insulin, clozapine enhance mealtime blood-glucose-lowering weeks eat and keep required, of (insulin the with alcohol by metabolic blood-glucose-lowering to lantus life-style from monitoring and patient's hypoglycaemia. to may reduced can adjustment be the you at pentamidine timing glargine may other control. transition of the in substances adjustment insulin could susceptibility experience is energy. in should types regimen of additional necessary. pentoxifylline, after insulin antidiabetic insulin of to of that somatropin, required the patients analogues in to when medicinal lantus or example, by may effect slowly regular usual by insulin increase 24 derivatives, type sensitivity that number of concomitant have the increase blood-glucose-lowering mellitus normal. treatment analogues, another hypoglycaemia, twice potentiate may of antibiotics. as does during olanzapine) hypoglycaemia, a is in

$152.16